Zdrojewicz Z
Pol Tyg Lek. 1989;44(7-8):185-7.
The activity of converting enzyme was determined in 19 patients with Cushing's disease using Friedland and Silverstein technique. Statistically significant increase in the activity of this enzyme was noted in the majority of the examined patients in comparison with healthy subjects. Therefore, inhibitors of the converting enzyme (Captopril) are justified in the treatment of the arterial blood hypertension in Cushing's disease.
采用弗里德兰德和西尔弗斯坦技术，对19例库欣病患者的转化酶活性进行了测定。与健康受试者相比，大多数受检患者的这种酶活性有统计学意义的升高。因此，转化酶抑制剂（卡托普利）在库欣病动脉高血压的治疗中是合理的。
